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Abstract 
This study is an in-depth examination of at whose initiative (participant, physician or screening programme) 
individuals participate in cervical, breast and colorectal cancer screening across the EU-28. Special attention is 
paid to (1) the association with educational attainment and (2) the country’s cancer screening strategy (organised, 
pilot/regional or opportunistic) for each type of cancer screened. Data were obtained from Eurobarometer 66.2 
‘Health in the European Union’ (2006). Final samples consisted of 10,186; 5,443 and 9,851 individuals for 
cervical, breast, and colorectal cancer, respectively. Multinomial logistic regressions were performed. 
Surprisingly, even in countries with organised screening programmes, participation in screenings for cervical, 
breast and colorectal cancer was most likely to be initiated by the general practitioner (GP) or the participant. In 
general, GPs were found to play a crucial role in making referrals to screenings, regardless of the country’s 
screening strategy. The results also revealed differences between educational groups with regard to their incentive 
to participate in cervical and breast cancer screening and, to a lesser extent, in colorectal cancer screening. People 
with high education are more likely to participate in cancer screening at their own initiative, while people with less 
education are more likely to participate at the initiative of a physician or a screening programme. Albeit, the results 
varied according to type of cancer screening and national screening strategy. 
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Introduction 
Each year, cancer is diagnosed in around 3.2 million Europeans. In addition to being a major cause of suffering 
and death, it is thus also a priority of health policy in the European Union [1, 2]. Deaths from cervical, breast or 
colorectal cancer comprise a substantial proportion of all cancer deaths in the EU [1]. In 2003, the European 
Council strongly advocated the development and implementation of national screening programmes for cervical, 
breast and colorectal cancer in all EU Member States [3]. This was motivated by the fact that early detection 
through systematic evidence-based cancer screening enhances the possibility of treating these cancers 
appropriately in an early stage, thereby greatly increasing the likelihood of cure [4] while reducing the rate of 
morbidity and mortality [3, 5, 6]. In addition to being beneficial for the individuals concerned, cancer screening is 
beneficial to society as a whole, as it can minimise the economic and social burden of cancer [1].  
Despite these advantages, participation in cancer screenings is affected by many factors at the individual level (e.g. 
education, income, occupation, ethnicity, gender, marital status, social support, age, psychosocial factors), as well 
as at the contextual level (e.g. screening strategies, health-system characteristics, and invitation strategies, along 
with social, cultural and environmental factors) [7, 8]. At the individual level, especially educational attainment is 
a crucial predictor of participation in cancer screenings. Compared to those with less education, people with higher 
levels of education are more likely to participate in screenings for cervical, breast and colorectal cancer [7, 9-14]. 
At the contextual level, the cancer screening strategy (e.g. organised or opportunistic) applied in a given country 
is being increasingly recognised as an important factor in cancer screening participation [1, 10, 11, 15-18]. In 
organised cancer screening, asymptomatic individuals within a given age range and sex (i.e. the target at-risk 
population) are systematically identified and invited to participate in a population-based programme, which is 
characterised by universal coverage and a quality-assurance structure [10, 19]. In contrast, opportunistic cancer 
screening involves offering screening tests through the primary healthcare system or in other healthcare settings 
[20]. Opportunistic strategies thus make participation dependent on the initiative of the individual or the treating 
physician. As stated by the European Council Recommendation, [3] and as established by previous research [10, 
11, 17, 18, 20], organised screening programmes are better equipped to reduce social inequalities in participation, 
in addition to being more cost-effective and efficient.  
Although previous studies have identified the cancer screening strategies used in European countries for each type 
of cancer screened and specified how these strategies affect participation rates (including in terms of educational 
attainment [1, 19, 21-23]), little is known about the parties instigating participation in cancer screening and whether 
this varies across countries according to their screening strategies. More specifically, existing studies have not 
specified whether the observed participation in cancer screening was at the initiative of the participant, a physician 
or a screening programme. It is therefore unclear whether the elevated participation rates usually observed in 
countries with organised cancer screening programmes [11, 16] are actually due to increases in participation 
resulting from these programmes, or whether they reflect increases in participation at the initiative of participants 
or physicians. In addition, while previous studies have provided evidence of differences in participation according 
to educational attainment, none of these studies has investigated possible differences between educational groups 
with regard to their incentive to participate. The central aim of this study is therefore to investigate at whose 
initiative (e.g. participant, physician or screening programme) individuals participate in cervical, breast and 
colorectal cancer screening across all EU-28 countries. Special attention is directed towards national cancer 
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screening strategies for each type of cancer screened and differences amongst educational groups with regard to 
the initiative to participate in cancer screening.  
When comparing the parties who might take the initiative in cancer screening participation (e.g. participant, 
physician and programme), participation at the individual’s initiative can be treated as an independent decision, 
while participation at the initiative of a physician or programme could be regarded as a shared or influenced 
decision. In turn, differences in the participant’s share in the screening decision might be associated with 
differences in educational attainment. Previous studies have indicated that people with higher levels of education 
tend to have better decision-making abilities and greater engagement in risk-control behaviours, while people with 
lower levels of education tend to have more fatalistic beliefs about cancer [24]. In addition to implicating the 
decision-making of people with lower levels of education with regard to cancer screenings, this also reduces the 
likelihood that they will take the initiative themselves to use opportunities for early detection [25-27]. We therefore 
expect people with higher levels of education to be more likely to decide to participate in cancer screening, as 
compared to people with less education, independent of advice from a physician or invitation from a screening 
programme.  
H1: People with higher levels of education are more likely to participate in cancer screening at their own 
initiative than are those with less education. 
 
On the other hand, when cancer screening is encouraged by third parties (e.g. physicians or screening 
programmes), people with lower levels of education might be more likely to be persuaded to participate. Mounting 
evidence suggests that recommendations from family physicians can considerably increase the likelihood of 
engaging in cancer screening [28-32]. In addition, previous studies have established that people with lower levels 
of education tend to have more frequent contact with their general practitioners (GP) than do those with more 
education, even if their less favourable health status is taken into account [33]. In addition to the treating physician, 
evidence is increasingly supporting the proposition that organised screening programmes might also narrow the 
educational gap in cancer screening participation [10, 11, 17, 18, 20]. Both financial and non-financial barriers 
(e.g. the burden of arranging screening) are greater when there is no screening programme (i.e. within the context 
of opportunistic screening), as responsibility for overcoming these barriers falls solely on the individual [10]. We 
therefore expect that people with lower levels of education are more likely to decide to participate in cancer 
screening if this decision is guided by a third party, particularly if they are guided by the treating physician or an 
invitation from a screening programme.   
H2: People with lower levels of education are more likely to participate in cancer screening at the 
initiative of a physician or screening programme than they are to participate at their own initiative. 
 
To the best of our knowledge, ours is the first study to conduct an in-depth exploration of the initiative for the 
decision to participate in cancer screening and its association with educational attainment across screenings for 
different types of cancer, across cancer screening strategies and across European countries. 
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Materials and methods 
Dataset 
Data were obtained from a large population-based survey: Eurobarometer 66.2, Health in the European Union 
[dataset] [34]. In the current study, final sample sizes correspond to the country-specific target population for each 
type of cancer screened, given the wide variations that continue to exist across the EU-28, [3] despite the guidelines 
of the European Commission concerning the appropriate target population (women between 25 and 64 years of 
age for cervical cancer, women between 50 and 69 years for breast cancer, and men and women from 50 to 74 
years old for colorectal cancer). In absence of country-specific information on the target population, we adopted 
the European guideline for that country. Data concerning the countries’ target populations and screening strategies 
for cervical, breast and colorectal cancer in 2006 were obtained from studies by Altobelli and Lattanzi [21], 
Altobelli and colleagues [21], Anttila and colleagues [23], Bastos and colleagues [19], Karsa and colleagues [1] 
and the International Agency for Research on Cancer (IARC) [35]. We considered a country’s cancer screening 
strategy opportunistic if there was no formal programme in 2006 and organised if there was a population-based 
programme in 2006. Countries with pilot programmes or regional programmes in 2006 were merged into the 
category ‘pilot/regional’. The final sample sizes were as follows: 10,186 women for cervical cancer screening, 
5,443 women for breast cancer screening and 9,851 men and women for colorectal cancer screening, after 
excluding cases with missing information (182 [1.8%], 93 [1.7%], and 209 [2.1%], respectively) and the 
individuals who had been diagnosed with cancer at the time of the interview (1035 [3.8%]).  
Variables  
The three dependent variables were participation in screening for cervical, breast and colorectal cancer. 
Respondents were asked whether they had participated in a cervical smear test, a mammography or a colorectal 
cancer test in the preceding 12 months. The available answers were ‘Yes, at my own initiative’, ‘Yes, at a doctor’s 
initiative’, ‘Yes, through a screening programme’ and ‘No’. Educational attainment was determined by the age at 
which respondents had completed full-time education. For the current study, this variable was categorised into the 
following categories, which roughly correspond to primary, secondary and tertiary education [36]: (1) ‘Completed 
education at 15 years of age or younger’ (2) ‘Completed education between 16 and 19 years of age’ (3) ‘Completed 
education at 20 years of age or older’. There was accounted for age, gender (0=male, 1=female), work status 
(0=employed, 1=unemployed, 2=non-employed [retired and house persons]), marital status (0=no partner, 
1=partner) and self-reported health (SRH) (0=poor, 1=good), given that previous research has identified these 
variables as confounding factors in the investigation of cancer-screening participation [9, 10, 37, 38]. 
Statistical analysis 
In the first step, the participation rate for cervical, breast and colorectal cancer screening in the preceding 12 
months was calculated for each EU-28 country, both in general and organised according to participant’s initiative, 
physician’s initiative and screening programme’s initiative. For each type of cancer screened, the countries were 
presented according to their screening strategies (organised, pilot/regional and opportunistic). Descriptive statistics 
were also calculated for gender, work status, marital status, SRH and cancer-screening participation (%, N) and 
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age (mean, S.E.), by educational level and by cancer screening strategy. Due to space limitations, these results are 
displayed in the appendix. In the second step, multinomial logistic regressions were performed to examine whether 
educational attainment was related to the initiation of cancer screening participation. In order to compare each 
initiator, we performed the analyses three times, each time with a different initiator (participant, physician and 
programme) as the reference category. We also performed the analyses separately for countries with organised 
screening, pilot/regional screening and opportunistic screening. In the case of opportunistic screening, we omitted 
respondents who had reported participation at the initiative of a programme in screening for cervical (N=377, 3.7% 
[377/10186]), breast (N=96, 1.8% [96/5443]) and colorectal cancer (N=92, 0.9% [92/9851]), as these countries 
lack such programmes. To account for possible similarities amongst individuals living in the same country, we 
included country-fixed effects [39]. Due to the inclusion of N-1 country dummies, the models automatically control 
for all between-country heterogeneity of cancer screening participation. Regression coefficients were presented as 
odds ratios (ORs), along with their 95% confidence intervals (CIs) to facilitate interpretation. The ORs and CIs for 
colorectal cancer screening in countries with an organised screening programme are not presented, as this model 
was invalid due to singularities (cells with a frequency equal to 0) in the Hessian matrix [40]. 
Results 
Variations across the EU-28 in terms of screening strategies, target populations and cancer-screening participation 
rates are outlined in Tables 1 through 3, both in general and according to initiative. The odds ratios of the 
multinomial logistic regressions, concerning the association between educational attainment and the initiative of 
cancer screening participation are presented in Table 4. 
Overall cancer screening participation  
Compared to the overall screening participation rates in Europe for cervical cancer (48.2%, Table 1) and breast 
cancer (46.9%, Table 2) in the preceding 12 months, the overall participation rate for colorectal cancer screening 
was much lower (9.6%, Table 3). This result is probably due to the fact that, at the time of the survey, colorectal 
cancer screening had only recently been launched in most countries. In the case of breast cancer screening, overall 
participation differed primarily according to cancer screening strategy, with substantially more participation in 
countries with organised screening (52.5%) than in countries with opportunistic screening (33.9%) (Table 2).  
[Table 1 through 3 about here] 
Initiative for cancer screening participation 
Tables 1 through 3 reveal substantial variation in the party (e.g. participant, physician or screening programme) 
taking the initiative to participate in cervical, breast and colorectal cancer screening across the types of cancer 
screened and across the screening strategies of the various countries. One particularly striking result is that, even 
in countries with organised cancer screening programmes, the participant or the GP were the most common 
initiators of participation, especially in the case of screening for cervical cancer (Table1) and colorectal cancer 
(Table 3). Only for organised breast cancer screening was participation initiated by a screening programme more 
common, especially in the Netherlands and Sweden, where 81% (Netherlands) and 82.4% (Sweden) of all 
participating women had been encouraged to participate by a screening programme (Table 2). These two countries 
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also stand out with regard to participation in cervical cancer screening, as they were the only countries in which 
the organised screening programme also appeared to be the main initiator, for 54.2% (Netherlands) and 63.4% 
(Sweden) of all women participating (Table 1). 
A second noteworthy result is that, in countries with opportunistic screening for breast and colorectal cancer, most 
participants were not screened at their own initiative, but at the advice of their GP. The recommendations of GPs 
appear to have been highly decisive, especially for colorectal cancer screening, given that most participation had 
been guided by their treating physicians. This result was observed in the 2 countries with organised screening, in 
6 of the 8 countries with pilot/regional screening and in 10 of the 18 countries with opportunistic screening, with 
the UK (75%) and Poland (73.3%) leading the list (Table 3). Moreover, across all EU-28 countries, GPs appeared 
to be the main reason for participation in screening for cervical cancer (42.3%, Table 1), breast cancer (38.3%, 
Table 2) and colorectal cancer (44.5%, Table 3). These results demonstrate the important role of GPs in making 
referrals to cancer screenings, particularly in countries without organised screening programmes. One exception 
was observed in countries with pilot/regional or opportunistic screening for cervical cancer, where the initiative 
most commonly came from the participants. Especially in Malta (69.5%), Greece (67.4%), Poland (61.6%) and 
Cyprus (61%), noticeably high screening rates at the participant’s initiative were observed (Table 1).  
[Table 4 around here] 
As illustrated in Table 4, differences in the initiative for the decision to participate in screening for cervical, breast 
and colorectal cancer are related to educational attainment. The results provide partial confirmation for the 
hypotheses that people with higher levels of education are more likely to participate in cancer screening at their 
own initiative than are those with less education (H1) and that people with lower levels of education are more 
likely to participate in cancer screening at the initiative of a physician or screening programme than at their own 
initiative (H2). The results varied according to type of cancer screening and national screening strategy. With 
regard to cervical cancer screening, in countries with organised screening programmes, women with lower levels 
of education participated significantly more at the programme’s initiative (OR=2.45; 95% CI 1.25-4.83) than at 
their own initiative. In the case of breast cancer screening, in countries where mammography was in a pilot phase 
or organised only in some regions, women with lower levels of education were more likely to participate at the 
initiative of a GP (OR=2.22; 95% IC 1.49-3.32) or a screening programme (OR=1.66; 95 % IC 1.08-2.56) than at 
their own initiative. In countries in which breast cancer screening was organised nationally, women with less 
education were more likely than those with more education were to respond to the invitation of a screening 
programme than to be screened at the advice of a GP (OR=1.84; 95% CI 1.14-2.95). Differences between 
educational groups with regard to the initiative to participate were less pronounced in the case of colorectal cancer 
screening. 
Discussion 
This study provides an in-depth examination of the parties (e.g. participant, physician or screening programme) at 
whose initiative individuals participate in screening for cervical, breast and colorectal cancer across all EU-28 
countries, according to the countries’ cancer screening strategies, with particular attention to associations with 
educational attainment.  
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One important finding is that, even in countries with organised screening programmes, participation in screening 
for cervical, breast and colorectal cancer was driven primarily by the GP or the participant. This might indicate 
that these organised screening programmes are unable to engage participants independently. Previous studies have 
demonstrated that the involvement of a GP in decision-making concerning screening increases participation in 
cancer screening programmes, relative to personal invitation letters for screening programmes [31, 41]. Another 
possible explanation is that cancer screening participants might not have been aware that they had taken part in a 
programme. Breast cancer was the only case in which screening programmes seemed to be more influential: such 
programmes were the principal initiators in almost half of the countries with organised screening. Breast cancer 
screening is more widespread and more promoted in the European population than is screening for cervical or 
colorectal cancer, due to more regular awareness campaigns [42, 43]. Greater awareness of breast cancer screening 
programmes might therefore explain the substantially higher rate of participation at the initiative of a national 
programme in the case of breast cancer.  
Sweden and the Netherlands had remarkably high proportions of participation at the initiative of their screening 
programmes for cervical and breast cancer. Both countries were amongst the first European countries to adopt 
organised screening programmes for breast cancer (since 1986 and 1989, respectively) and cervical cancer (since 
the end of the 1960s and 1996, respectively) [23, 44]. Moreover, both countries have high coverage for both types 
of cancer screenings, and both maintain good registers that allow for regular monitoring and continuous evaluation 
of effectiveness and quality at the regional and national levels. It should be noted that Sweden ‘integrates’ 
opportunistic and organised screening for cervical cancer. If women prefer to go to a physician at their own 
initiative for a pap test, that test is registered and the next invitation to participate in the screening programme is 
postponed [23]. This reduces the incidence of over-screening for cervical cancer.  
Despite European recommendations for triennial screening, previous research indicates that over-screening and 
unnecessary screening (at intervals of less than 3 years) for cervical cancer remain common, especially in absence 
of organised screening strategies [15, 45]. Our results might also reflect over-screening, as they revealed large 
proportions of cervical cancer screening at the participant’s initiative. This was particularly true of Malta, Cyprus, 
Greece and Poland, all of which have semi-opportunistic (pilot/regional) or fully opportunistic screening strategies. 
The undesirable consequences of over-screening include false-positive results and follow-up examinations, undue 
psychological stress for women without cervical cancer and unnecessary financial costs [46].  
One surprising finding is that, in countries with opportunistic screening strategies for cervical, breast or colorectal 
cancer, it was not the participant but the GP who appeared to be the main driver of participation. In the absence of 
an organised screening programme, GPs thus appear to be important external motivators for cancer screening 
participation. Moreover, our results displayed that, regardless of the cancer screening strategy applied and across 
all EU-28 countries, the initiative to participate in screening for cervical, breast and colorectal cancer came 
primarily from GPs. This result underscores the GP’s pivotal role in making referrals to specialised medicine (e.g. 
cancer screenings). General practitioners do indeed have strong persuasive power in convincing their patients to 
undergo cancer screening [28-32]. Previous studies have also demonstrated that patients’ perceptions of their 
physicians’ confidence in cancer screening is an important predictor of compliance with their advice, as such 
confidence communicates the importance of the screening to the patient [32, 47].  
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While previous studies have reported educational inequalities in favour of people with higher levels of education 
with regard to participation in screening for cervical, breast and colorectal cancer [7, 9-14], our results indicate 
that participants’ education also plays a role, particularly with regard to the manner in which they were guided in 
the decision to be screened. The results partially confirm our expectations that people with higher levels of 
education are more likely to participate in cancer screening at their own initiative than are those with less education 
(H1) and that people with lower levels of education are more likely to participate in cancer screening at the 
initiative of a physician or a screening programme than at their own initiative (H2). In the presence of a nationally 
organised screening programme for cervical cancer, women with higher levels of education were more likely to 
participate at their own initiative, while those with less education were more likely to respond to the invitation of 
a screening programme. This was also the case for breast cancer screening (in the pilot phase or organised only in 
some regions). Moreover, in this context, the decisions of women with less education to undergo mammograms 
were also more likely to be guided by their treating physicians than by their own initiative. This finding 
corresponds to previous research indicating that people with higher levels of education are better equipped to take 
independent decisions concerning engagement in risk-control behaviours [24]. In contrast, people with less 
education apparently need more guidance, advice or persuasion from third parties (e.g. GPs or invitation letters 
from screening programmes) to orient their decisions to participate in screening. In countries with nationally 
organised screening programmes for breast cancer, however, we found that women with higher levels of education 
were more likely to participate at the advice of the GP than through a screening programme, as compared to their 
counterparts with less education. According to Mirowsky and Ross [48], people with higher levels of education 
are better able to acquire information. One possible explanation for this finding might thus be that women with 
more education are more aware of the ongoing mammography debate, which highlights the harm and risks of over-
diagnosis and over-treatment [49]. They might therefore prefer to hear the advice of their GPs before deciding to 
participate in a screening programme.  
While this study provides valuable new insight into the initiation of cancer screening participation and its relation 
to educational inequalities, it is subject to several limitations. First, the cross-sectional research design limits the 
causal interpretation of the results. Nonetheless, previous studies have provided compelling evidence of a causal 
relationship running from more schooling to better health [50-52]. Additionally, in the current study, all outcomes 
occurred after the respondents had completed their education. Second, educational attainment was measured only 
by the age at which respondents had completed formal education. We were therefore unable to consider the wide 
differences of educational programmes within and between European countries, even if their duration is identical 
[36]. Third, despite European guidelines for a biennial screening interval for breast cancer and a triennial one for 
cervical and colorectal cancer [3], the Eurobarometer only asked about cancer screening participation in the 
preceding 12 months. The results may therefore underestimate actual participation rates. Fourth, the validity of the 
results might be somewhat questionable, as the Eurobarometer relies on self-reported data, which are contingent 
on social experiences [53]. For example, some respondents in countries without screening programmes 
nevertheless reported participating through such programmes. Some respondents might not have known exactly 
what was meant by a screening programme. To account for this possibility, we omitted these cases from the 
multinomial logistic regressions. Their elimination had no effect on the results, as they did not significantly differ 
in educational level, work status, marital status, SRH or gender. Further, we considered GPs synonymously with 
physicians. This might not always have been the case, however, particularly for cervical cancer screening in 
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Luxembourg [54], Croatia [55], Slovakia [56] and other countries (where gynaecologists are in charge of taking 
pap smears). In similar vein, we also did not consider possible differences in the GP’s involvement in cancer 
screenings across the EU-28 according to cancer screening strategies and local healthcare policies [30]. Future 
studies should address such cross-national differences, as they might be important contextual factors for cancer 
screening participation. Finally, the Eurobarometer data are from 2006. The Eurobarometer is nevertheless the 
most recent and only international European survey including information on the initiation of cancer screening 
participation for different types of cancer, comparable across all EU-28 countries. Once more recent and 
comparable data are available, future studies should investigate whether the findings of the current study still hold.  
Conclusion and implications 
This study adds to the existing literature by identifying education-related differences in the parties taking the 
initiative in decisions concerning participation in cancer screening. It also provides an outline of screening 
participation – overall and according to initiative – in every European country. This reveals that screening 
programmes in countries with organised screening are unable to be the main drivers of cancer screening 
participation. Instead of depending entirely on the provision of written information [57], screening programmes 
would do well to increase their response to the explicit involvement of physicians in preventive counselling [30, 
31, 41]. Explicit information exchange between providers and patients concerning risks and benefits has been 
acknowledged as a crucial predictor of cancer screening participation [31, 57, 58]. As illustrated in some previous 
studies, however, the actual involvement of GPs, which is costly and time consuming, is even not necessary, as 
participation rates are also increased by personal invitation letters signed by or mentioning the GP, or accompanied 
by a letter from the GP prompting participation in screening [30, 59] for breast [60], cervical [61, 62] and colorectal 
cancer [63]. Future research is nevertheless needed in order to identify whether screening programmes actually do 
face initiation problems or whether the observed low proportions of participants initiated by screening programmes 
are due to a lack of awareness amongst participants that they had taken part in a screening programme.  
Further, our results highlight the pivotal role of GPs, as physicians were identified as the primary initiators of 
participation in screening for cervical, breast and colorectal cancer across the EU-28. The frequency of physician-
patient consultations, the physician’s knowledge of the patient’s familial and social background, and the credibility 
of the family physician offer considerable potential for cancer prevention [28]. Fostering the role of GPs and 
encouraging them to engage actively in promoting screening to the appropriate target population is an important 
key factor in reducing educational inequalities in cancer screening participation [31, 41]. In this light, GPs should 
be more aware of their vital role as navigators to cancer screenings [37]. Patients identify the lack of a 
recommendation from the treating physician as an important reason for not participating in cancer screenings [32]. 
In addition, GPs should become more conscious about the vicious circle that might exist during consultations 
between themselves and patients with low levels of education [33, 64-66]. More specifically, patients with less 
education might ask fewer questions, state fewer opinions, articulate less affective expression and have less of a 
preference for decision-making during consultations, thus resulting in less involved behaviour, fewer partnership-
building utterances and a less active stance on the part of the GP. This might discourage such patients from 
adopting a more active communication style. Nevertheless, the GP’s ability to convey and explain a screening test 
and what it entails to the patient in a face-to-face setting might be one way to address educational inequalities in 
the uptake of cancer screenings [32]. In summary, despite emerging evidence and growing recognition of the 
11 
 
importance of more engagement on the part of GPs in cancer control, including prevention, early diagnosis and 
screening, substantial potential remains [30].  
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Table 1 Number of cases, participation rate (%) (overall and by initiative) in cervical cancer screening in the preceding 12 
months amongst women within the appropriate age range, by country of residence and type of cancer screening strategy 
(N=10,186) 
 
Screening strategy and 
country 
N 
Age 
range 
Overall 
participation 
% 
Participation by initiative 
Participant 
% 
Physician 
% 
Programme 
% 
Organised 2907  43.2 30.5 41.8 27.7 
Netherlands 304 30-60 31.6 17.7 28.1 54.2 
Estonia 257 30-59 29.2 48 49.3 2.7 
Finland 327 25-65 51.7 34.9 32 33.1 
Sweden 297 23-60 44.1 11.5 25.2 63.4 
UK 460 20-64 41.7 17.2 54.2 28.6 
Denmark 258 23-59 41.9 23.1 52.8 24.1 
Slovenia 382 20-64 55.8 32.9 57.3 9.9 
Lithuania 258 30-60 40.7 34.3 44.8 21 
Hungary 364 25-65 46.2 55.4 26.2 18.5 
Pilot/regional 4109  52.9 39.6 46.5 13.9 
Austria 440 20+ 69.3 28.5 39.3 32.1 
Luxembourg 244 15+ 66 39.8 46 14.3 
France 359 20-65 61.8 21.6 75.7 2.7 
Belgium 358 25-64 63.7 36.8 55.7 7.5 
Portugal 353 25-64 50.7 18.4 78.8 2.8 
Italy 475 25-64 52 43.3 28.7 27.9 
Croatia 369 /a 53.1 56.6 30.6 12.8 
Spain 373 18-65 41.6 23.9 49.7 26.5 
Greece 487 20+ 46 67.4 29.5 3.1 
Poland 308 25-59 40.6 61.6 36 2.4 
Ireland 343 25-60 38.2 46.6 46.6 6.9 
Opportunistic 3170  46.7 38 36.5 25.5 
Germany 706 20+ 54.5 50.9 29.1 20 
Latvia 487 20-70 61 35.7 51.5 12.8 
Cyprus 167 30-60 49.1 61 20.7 18.3 
Malta 221 / 53.4 69.5 23.7 6.8 
Czech Republic 484 25-69 47.5 13.5 36.1 50.4 
Slovakia 502 23-64 56 21.7 38.4 39.9 
Romania 318 25-65 9.4 33.3 60 6.7 
Bulgaria 285 31-65 19.6 46.4 37.5 16.1 
EU-28 10186  48.2 36.8 42.3 20.9 
Notes. a  No information available 
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Table 2 Number of cases, participation rate (%) (overall and by initiative) in breast cancer screening in the preceding 12 
months amongst women within the appropriate age range, by country of residence and type of cancer screening strategy 
(N=5,443) 
 
Screening strategy and 
country 
N 
Age 
range 
Overall 
participation 
% 
Participation by initiative 
Participant 
% 
Physician 
% 
Programme 
% 
Organised 1942  52.5 21.6 28.9 49.5 
Luxembourg 78 50-69 71.8 21.4 17.9 60.7 
France 154 50-74 72.1 18.9 42.3 38.7 
Belgium 148 50-69 66.2 31.6 40.8 27.6 
Netherlands 200 50-75 60.5 7.4 11.6 81 
Finland 185 50-69 54.6 12.9 14.9 72.3 
Sweden 277 40-74 55.2 7.2 10.5 82.4 
UK 218 50-70 40.4 12.5 27.3 60.2 
Croatia 171 50-69 41.5 39.4 47.9 12.7 
Cyprus 108 50-69 44.4 35.4 35.4 29.2 
Lithuania 197 50-69 23.4 30.4 63 6.5 
Hungary 206 45-65 61.7 41.7 38.6 19.7 
Pilot/regional  1869  52.3 30.9 42.7 26.4 
Austria 240 40-69 72.1 32.4 37.6 30.1 
Germany 237 50-69 46.4 60.9 22.7 16.4 
Denmark 161 50-69 21.1 44.1 32.4 23.5 
Estonia 102 50-59 53.9 25.5 21.8 52.7 
Ireland 119 50-64 44.5 35.8 26.4 37.7 
Poland 160 50-69 39.4 54 39.7 6.3 
Portugal 229 45-69 69 14.6 80.4 5.1 
Spain 188 45-70 46.3 13.8 51.7 34.5 
Italy 152 50-69 62.5 29.5 32.6 37.9 
Czech Republic 281 45-69 53.4 22.7 42 35.5 
Opportunistic 1632  33.9 34.8 47.8 17.3 
Latvia 171 50-69 38 41.5 43.1 15.4 
Slovenia 200 50-69 37 28.4 71.6 0 
Greece 195 40-64 45.6 46.1 50.6 3.4 
Malta 116 /a 29.3 55.9 26.5 17.6 
Slovakia 453 40+ 49.7 25.3 43.6 31.1 
Romania 164 50-69 8.5 64.3 35.7 0 
Bulgaria 333 40+ 15.9 35.8 50.9 13.2 
EU-28 5443  46.9 28 38.3 33.7 
Notes. a  No information available 
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Table 3 Number of cases, participation rate (%) (overall and by initiative) in colorectal cancer screening in the preceding 
12 months amongst women within the appropriate age range, by country of residence and type of cancer screening 
strategy (N=9,851) 
 
Screening strategy and 
country 
N 
Age 
range 
Overall 
participation 
% 
Participation by initiative 
Participant 
% 
Physician 
% 
Programme 
% 
Organised 461  9.8 28.9 44.4 26.7 
Finland 183 60-69 11.5 23.8 42.9 33.3 
Italy 278 50-74 8.6 33.3 45.8 20.8 
Pilot/regional 2766  11.2 18.1 47.9 34 
Austria 372 50+ 27.2 14.9 26.7 58.4 
France 317 50-74 16.1 23.5 47.1 29.4 
Sweden 201 50-60 2.5 20 40 40 
UK 575 45-74 5.6 6.3 75 18.8 
Latvia 327 50-74 16.5 29.6 53.7 16.7 
Spain 215 50-69 7 13.3 60 26.7 
Slovenia 313 50-69 3.5 27.3 63.6 9.1 
Czech Republic 446 50+ 9 12.5 65 22.5 
Opportunistic 6624  9 41.8 42.7 15.5 
Germany 592 50-74 31.8 51.6 34.6 13.8 
Luxembourg 172 / 19.2 54.5 39.4 6.1 
Belgium 353 50-75 10.5 32.4 54.1 13.5 
Netherlands 298 55-75 4.7 57.1 35.7 7.1 
Denmark 459 45-75 8.3 18.4 55.3 26.3 
Estonia 389 50-74 3.3 46.2 46.2 7.7 
Ireland 224 55-74 10.3 39.1 52.2 8.7 
Portugal 297 50-70 12.8 39.5 50 10.5 
Croatia 335 50-74 3.6 25 58.3 16.7 
Greece 455 50+ 7 56.3 37.5 6.3 
Cyprus 260 50+ 3.1 62.5 25 12.5 
Malta 214 / 3.3 28.6 57.1 14.3 
Lithuania 384 / 7.3 42.9 35.7 21.4 
Poland 217 50-65 6.9 26.7 73.3 0 
Slovakia 491 50+ 9.4 32.6 34.8 32.6 
Hungary 365 50-70 4.9 11.1 66.7 22.2 
Romania 353 50-74 3.1 36.4 36.4 27.3 
Bulgaria 772 31+ 4.4 35.3 44.1 20.6 
EU-28 9851  9.6 33.5 44.5 22 
Notes. a  No information available 
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Table 4 Multinomial logistic regression models for the association between educational level (reference category= tertiary education) and participation 
in cervical, breast and colorectal cancer screening (No; Yes, on own initiative; Yes, at the physician’s initiative; Yes, at the programme’s initiative), by 
type of cancer screening strategy a 
Cervical cancer 
screening 
Model 1  Model 2  Model 3 
Reference category 
dependent variable 
Participant’s initiative  Physician’s initiative  
Programme’s 
initiative 
 No  Physician  Programme  No  Programme  No 
Organised            
Primary education 2.29 b *** 
(1.30-4.03) 
 
1.81  
(0.95-3.47) 
 
2.45 ** 
(1.25-4.83) 
 
1.27 
(0.82-1.96) 
 
1.36 
(0.77-2.40) 
 
0.93 
(0.59-1.48) 
Secondary education 1.69 *** 
(1.17-2.44) 
 
1.35  
(0.89-2.07) 
 
1.74 * 
(1.12-2.71) 
 
1.25 
(0.92-1.69) 
 
1.29 
(0.87-1.90) 
 
0.97 
(0.71-1.34) 
            
Pilot/regional            
Primary education 2.04 *** 
(1.58-2.64) 
 
1.11 
(0.82-1.49) 
 
0.96 
(0.65-1.41) 
 
1.85 *** 
(1.46-2.34) 
 
0.91 
(0.67-1.22) 
 
2.14 *** 
(1.51-3.02) 
Secondary education 1.57 *** 
(1.30-1.90) 
 
1.12 
(0.90-1.38) 
 
0.93 
(0.69-1.27) 
 
1.40 *** 
(1.18-1.67) 
 
0.90 
(0.72-1.11) 
 
1.68 *** 
(1.26 -2.24) 
            
Opportunistic            
Primary education 2.80 *** 
(2.05-3.84) 
 
1.38 
(0.92-2.09) 
 -  
2.05 *** 
(1.38-2.97) 
 -  - 
Secondary education 2.02 *** 
(1.56-2.62) 
 
1.44 *  
(1.05-1.98) 
 -  
1.40 
(1.04-1.89) 
 -  - 
Breast cancer 
screening 
Model 1  Model 2  Model 3 
Reference category 
dependent variable 
Participant’s initiative  Physician’s initiative  
Programme’s 
initiative 
 No  Physician  Programme  No  Programme  No 
Organised            
Primary education 1.07 
(0.59-1.92) 
 
0.67 
(0.35-1.26) 
 
1.23 
(0.67-2.26) 
 
1.60 * 
(1.02-2.51) 
 
1.84 * 
(1.14-2.95) 
 
0.87 
(0.60-1.26) 
Secondary education 0.86 
(0.51-1.45) 
 
0.53 * 
(0.30-0.93) 
 
0.70 
(0.40-1.20) 
 
1.64 * 
(1.09-2.45) 
 
1.32 
(0.86-2.04) 
 
1.24 
(0.88-1.74) 
            
Pilot/regional            
Primary education 2.10 *** 
1.53-2.88 
 
2.22 *** 
(1.49-3.32) 
 
1.66 * 
(1.08-2.56) 
 
0.94 
(0.66-1.35) 
 
0.75 
(0.47-1.18) 
 
1.26 
(0.85-1.88) 
Secondary education 1.79 *** 
(1.32-2.41) 
 
1.53 * 
(1.04-2.27) 
 
1.30 
(0.85-1.99) 
 
1.16 
(0.81-1.67) 
 
0.85 
(0.53-1.35) 
 
1.37 
(0.92-2.05) 
            
Opportunistic            
Primary education 4.63 *** 
(1.94-11.05) 
 
1.83 
(0.64-5.21) 
 -  
2.53 * 
(1.12-5.71) 
 -  - 
Secondary education 2.46 * 
(1.22-4.93) 
 
1.34 
(0.58-3.10) 
 -  
1.83 
(0.91-3.68) 
 -  - 
Colorectal cancer 
screening c 
Model 1  Model 2  Model 3 
Reference category 
dependent variable 
Participant’s initiative  Physician’s initiative  
Programme’s 
initiative 
 No  Physician  Programme  No  Programme  No 
Pilot/regional            
Primary education 2.13 
(0.92-4.93) 
 
1.85 
(0.72-4.75) 
 
1.51 
(0.56-4.09) 
 
1.15 
(0.72-1.84) 
 
0.82 
(0.40-1.68) 
 
1.41 
(0.79-2.53) 
Secondary education 1.24  
(0.63-2.47) 
 
0.83 
(0.37-1.86) 
 
0.83 
(0.35-1.95) 
 
1.50 
(0.95-2.36) 
 
0.99 
(0.50-1.99) 
 
1.51 
(0.87-2.62) 
            
Opportunistic            
Primary education 2.10 *** 
(1.52-2.91) 
 
0.84 
(0.54-1.32) 
 -  
2.50 *** 
(1.75-3.58) 
 -  - 
Secondary education 1.59 ** 
(1.17-2.16) 
 
1.10 
(0.73-1.66) 
 -  
1.44 * 
(1.05-2.0) 
 -  - 
Notes. a In each model another initiator category of the dependent variable is the reference category. All models are adjusted for age, work status, marital 
status, self-reported health, gender and country; b All coefficients are odds ratios (OR >1 = higher probability) with 95% confidence intervals; c Coefficients 
for organised colorectal cancer screening were not presented, as these were invalid due to singularities (cells with a frequency equal to 0) in the Hessian 
matrix. * p < .050; ** p < .010; *** p < .001  
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